HEADER ANTIBIOTIC 09-MAR-19 6QYU TITLE SOLUTION NMR OF SYNTHETIC ANALOGUES OF NISIN AND MUTACIN RING A AND TITLE 2 RING B - MUTACIN I RING A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHE-DHA-DAL-LEU-DHA-LEU-CYS-ALA; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: LACTOCOCCUS LACTIS; SOURCE 4 ORGANISM_TAXID: 1358 KEYWDS PEPTIDE ANTIBIOTIC, LANTIBIOTIC, ANTIMICROBIAL, BACTERIOCIN, KEYWDS 2 THIOESTER, ANTIBIOTIC EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR R.DICKMAN,S.A.MITCHELL,A.FIGUEIREDO,D.F.HANSEN,A.B.TABOR REVDAT 3 14-JUN-23 6QYU 1 LINK REVDAT 2 02-OCT-19 6QYU 1 JRNL REVDAT 1 11-SEP-19 6QYU 0 JRNL AUTH R.DICKMAN,S.A.MITCHELL,A.M.FIGUEIREDO,D.F.HANSEN,A.B.TABOR JRNL TITL MOLECULAR RECOGNITION OF LIPID II BY LANTIBIOTICS: SYNTHESIS JRNL TITL 2 AND CONFORMATIONAL STUDIES OF ANALOGUES OF NISIN AND MUTACIN JRNL TITL 3 RINGS A AND B. JRNL REF J.ORG.CHEM. V. 84 11493 2019 JRNL REFN ISSN 0022-3263 JRNL PMID 31464129 JRNL DOI 10.1021/ACS.JOC.9B01253 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.DICKMAN,E.DANELIUS,S.A.MITCHELL,D.F.HANSEN,M.ERDELYI, REMARK 1 AUTH 2 A.B.TABOR REMARK 1 TITL A CHEMICAL BIOLOGY APPROACH TO UNDERSTANDING MOLECULAR REMARK 1 TITL 2 RECOGNITION OF LIPID II BY NISIN: SOLID-PHASE SYNTHESIS AND REMARK 1 TITL 3 NMR ENSEMBLE ANALYSIS OF NISIN(1-12) AND A SYNTHETIC REMARK 1 TITL 4 ANA-LOGUE. REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XPLOR-NIH 2.45 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6QYU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1292101157. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.0 REMARK 210 IONIC STRENGTH : TFA SALT REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 5.0 MG/ML MUTACIN I RING A, DMSO REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H COSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-13C HSQC; 2D 1H-13C HMBC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XPLOR-NIH 2.45, CCPNMR ANALYSIS REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 250 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 DAL A 3 16.03 -82.08 REMARK 500 1 LEU A 6 -48.12 137.53 REMARK 500 1 CYS A 7 -12.04 -41.24 REMARK 500 2 DAL A 3 16.45 -68.81 REMARK 500 2 LEU A 6 -50.51 141.68 REMARK 500 2 CYS A 7 -24.07 -37.68 REMARK 500 3 DAL A 3 15.32 -77.26 REMARK 500 3 LEU A 6 -50.00 142.11 REMARK 500 4 DAL A 3 17.21 -68.24 REMARK 500 4 LEU A 6 -47.62 140.00 REMARK 500 4 CYS A 7 -8.11 -42.00 REMARK 500 5 DAL A 3 17.37 -75.22 REMARK 500 5 LEU A 6 -43.86 137.46 REMARK 500 5 CYS A 7 5.62 -47.21 REMARK 500 6 DAL A 3 16.98 -65.19 REMARK 500 6 LEU A 6 -50.54 141.14 REMARK 500 6 CYS A 7 -21.11 -35.56 REMARK 500 7 DAL A 3 16.41 -81.96 REMARK 500 7 LEU A 6 -49.33 139.57 REMARK 500 8 DAL A 3 14.15 -73.54 REMARK 500 8 LEU A 6 -52.38 144.13 REMARK 500 8 CYS A 7 -37.46 -34.54 REMARK 500 9 DAL A 3 17.46 -69.10 REMARK 500 9 LEU A 6 -44.97 138.17 REMARK 500 9 CYS A 7 -0.74 -44.42 REMARK 500 10 DAL A 3 15.14 -79.45 REMARK 500 10 LEU A 6 -50.68 141.23 REMARK 500 11 DAL A 3 16.79 -75.60 REMARK 500 11 LEU A 6 -47.18 138.12 REMARK 500 11 CYS A 7 -8.21 -42.06 REMARK 500 12 DAL A 3 18.21 -69.18 REMARK 500 12 LEU A 6 -49.12 139.95 REMARK 500 12 CYS A 7 -12.01 -39.72 REMARK 500 13 DAL A 3 17.11 -70.43 REMARK 500 13 LEU A 6 -47.03 136.15 REMARK 500 13 CYS A 7 -36.46 -38.54 REMARK 500 14 DAL A 3 17.25 -65.24 REMARK 500 14 LEU A 6 -46.56 135.26 REMARK 500 14 CYS A 7 -13.80 -39.75 REMARK 500 15 DAL A 3 18.53 -62.92 REMARK 500 15 LEU A 6 -44.60 138.36 REMARK 500 15 CYS A 7 2.07 -45.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WCO RELATED DB: PDB REMARK 900 RELATED ID: 6QTF RELATED DB: PDB REMARK 900 SOLUTION NMR OF SYNTHETIC MUTACIN I RING B, MAJOR CONFORMER REMARK 900 RELATED ID: 6QYR RELATED DB: PDB REMARK 900 SOLUTION NMR OF SYNTHETIC MUTACIN I RING B, MINOR CONFORMER REMARK 900 RELATED ID: 6QYS RELATED DB: PDB REMARK 900 SOLUTION NMR OF SYNTHETIC NISIN RING B REMARK 900 RELATED ID: 6QM1 RELATED DB: PDB REMARK 900 SOLUTION NMR OF SYNTHETIC NISIN RING B (LAN8,11) ANALOGUE REMARK 900 RELATED ID: 6QYT RELATED DB: PDB REMARK 900 SOLUTION NMR OF SYNTHETIC MUTACIN I RING A TRUNCATED ANALOGUE REMARK 900 RELATED ID: 34372 RELATED DB: BMRB REMARK 900 SOLUTION NMR OF SYNTHETIC ANALOGUES OF NISIN AND MUTACIN RING A AND REMARK 900 RING B - MUTACIN I RING A DBREF 6QYU A 1 8 PDB 6QYU 6QYU 1 8 SEQRES 1 A 8 PHE DHA DAL LEU DHA LEU CYS ALA HET DHA A 2 8 HET DAL A 3 9 HET DHA A 5 8 HETNAM DHA 2-AMINO-ACRYLIC ACID HETNAM DAL D-ALANINE HETSYN DHA 2,3-DIDEHYDROALANINE FORMUL 1 DHA 2(C3 H5 N O2) FORMUL 1 DAL C3 H7 N O2 LINK C PHE A 1 N DHA A 2 1555 1555 1.35 LINK C DHA A 2 N DAL A 3 1555 1555 1.34 LINK C DAL A 3 N LEU A 4 1555 1555 1.33 LINK CB DAL A 3 SG CYS A 7 1555 1555 1.81 LINK C LEU A 4 N DHA A 5 1555 1555 1.35 LINK C DHA A 5 N LEU A 6 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1